176 related articles for article (PubMed ID: 26391890)
1. Treatment of cancer patients in their last month of life: aimless chemotherapy.
Assi T; El Rassy E; Tabchi S; Ibrahim T; Moussa T; Chebib R; El Karak F; Farhat F; Chahine G; Nasr F; Ghosn M; Kattan J
Support Care Cancer; 2016 Apr; 24(4):1603-8. PubMed ID: 26391890
[TBL] [Abstract][Full Text] [Related]
2. The role of palliative care in the last month of life in elderly cancer patients.
Assi T; El Rassy E; Ibrahim T; Moussa T; Tohme A; El Karak F; Farhat F; Faddoul S; Ghosn M; Kattan J
Support Care Cancer; 2017 Feb; 25(2):599-605. PubMed ID: 27738795
[TBL] [Abstract][Full Text] [Related]
3. Total Parenteral Nutrition in Middle Eastern Cancer Patients at End of Life: Is it Justified?
Rassy E; Assi T; Bakouny Z; Ferkh R; Fakhoury M; Elias H; Tohme A; El Karak F; Chahine G; Nasr F; Ghosn M; Kattan J
Gulf J Oncolog; 2019 Sep; 1(31):21-25. PubMed ID: 31591987
[TBL] [Abstract][Full Text] [Related]
4. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy at the end of life: Uncommon clinical practice?].
Santos Pérez MI; Godoy Díez M; Abajo Del Álamo C
J Healthc Qual Res; 2019; 34(4):201-207. PubMed ID: 31713531
[TBL] [Abstract][Full Text] [Related]
6. Utilization of systemic palliative chemotherapy at the end of life: a local experience.
Abdul Monem E; Mehdi I; Al Bahrani BJ; Nada AM; Al Kharusi S
J Pak Med Assoc; 2014 Aug; 64(8):863-8. PubMed ID: 25252508
[TBL] [Abstract][Full Text] [Related]
7. Hospital end-of-life care in haematological malignancies.
Beaussant Y; Daguindau E; Chauchet A; Rochigneux P; Tournigand C; Aubry R; Morin L
BMJ Support Palliat Care; 2018 Sep; 8(3):314-324. PubMed ID: 29434048
[TBL] [Abstract][Full Text] [Related]
8. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients.
Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P
BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196
[TBL] [Abstract][Full Text] [Related]
9. End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care.
Thompson CA; Hugo SE; Swetz KM; Novotny PJ; Sloan JA; Loprinzi CL; Moynihan TJ; Shanafelt TD
BMJ Support Palliat Care; 2013 Jun; 3(2):181-7. PubMed ID: 24644566
[TBL] [Abstract][Full Text] [Related]
10. Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care.
Magarotto R; Lunardi G; Coati F; Cassandrini P; Picece V; Ferrighi S; Oliosi L; Venturini M
Tumori; 2011; 97(5):573-7. PubMed ID: 22158486
[TBL] [Abstract][Full Text] [Related]
11. Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution.
Jang TK; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
BMC Palliat Care; 2018 Aug; 17(1):99. PubMed ID: 30086748
[TBL] [Abstract][Full Text] [Related]
12. The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study.
Spilsbury K; Rosenwax L; Arendts G; Semmens JB
PLoS One; 2017; 12(9):e0185275. PubMed ID: 28934324
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.
Wein L; Rowe C; Brady B; Handolias D; Lipton L; Pook D; Stanley R; Haines I
Intern Med J; 2017 Mar; 47(3):280-283. PubMed ID: 27658500
[TBL] [Abstract][Full Text] [Related]
14. Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
Wu CC; Hsu TW; Chang CM; Lee CH; Huang CY; Lee CC
Oncologist; 2016 Jun; 21(6):771-7. PubMed ID: 27091417
[TBL] [Abstract][Full Text] [Related]
15. End-of-life care for hospitalized patients with metastatic melanoma in France: a nationwide, register-based study.
Gallais Sérézal I; Beaussant Y; Rochigneux P; Tournigand C; Aubry R; Lindelöf B; Morin L
Br J Dermatol; 2016 Sep; 175(3):583-92. PubMed ID: 27038100
[TBL] [Abstract][Full Text] [Related]
16. [Palliative care for patients with COPD: a challenge].
du Couëdic L; Morel V; Trehello L; Trehony A; Robert M; Sandron D
Rev Mal Respir; 2012 Nov; 29(9):1088-94. PubMed ID: 23200580
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Specialized Palliative Care Upon Initiation of First-Line Chemotherapy for Cancer Progression: Is It Early Enough?
Nakajima N; Abe Y
Am J Hosp Palliat Care; 2016 May; 33(4):340-5. PubMed ID: 25433067
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with the time to first palliative care consultation in Lebanese cancer patients.
Bakouny Z; Assi T; El Rassy E; Daccache K; Kattan C; Tohme A; Mouhawej MC; Kattan J
Support Care Cancer; 2019 Apr; 27(4):1529-1533. PubMed ID: 30406426
[TBL] [Abstract][Full Text] [Related]
19. Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006.
Liu TW; Chang WC; Wang HM; Chen JS; Koong SL; Hsiao SC; Tang ST
Acta Oncol; 2012 Apr; 51(4):505-11. PubMed ID: 22283469
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
